Albilad Bank Q3 profit hits 740M
Bravo Group, the company behind Nahdi Pharmacies and affiliated with the giant Saudi group, announced its third quarter 2026 interim financial results. The company recorded a 9% year-over-year increase in profits, reaching 500 million Riyals. This growth was driven by a 12% rise in sales, totaling 3.8 billion Riyals, supported by sector growth in healthcare and expansion of the pharmacy network. The company also experienced an improvement in gross profit margins and an increase in online sales of medicines. Additionally, it maintained a healthy level of liquidity, with assets rising by 8%. The growth in profits and market expansion are among the key highlights of this quarter, with expectations of continued positive performance in the upcoming periods.
Notice: This Is an AI-Generated Summary
Comments (0)